Revealing neuropilin expression patterns in pancreatic cancer: From single‑cell to therapeutic opportunities (Review)

Sikun Meng ¹, Tomoaki Hara ¹, Hiromichi Sato ^1,2

⁰Department of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.

Oncology Letters +

|

February 2, 2024

View abstract on PubMed

Summary

Neuropilin (NRP) proteins are key in pancreatic cancer progression and therapy resistance. Targeting NRP-1 and NRP-2 offers new therapeutic strategies for this fatal disease.

Area Of Science

Oncology
Molecular Biology
Cancer Research

Background

Pancreatic cancer is highly fatal, involving complex stromal and non-epithelial components.
Neuropilin (NRP) receptors, NRP-1 and NRP-2, are implicated in pancreatic cancer's biological behavior.
NRP proteins act as co-receptors for various growth factors crucial in cancer development.

Purpose Of The Study

To explore the diverse roles of NRP proteins in pancreatic cancer.
To investigate NRP protein involvement at the cellular level using single-cell analysis.
To identify NRP proteins as potential therapeutic targets for pancreatic cancer treatment.

Main Methods

Review of existing literature on NRP proteins in pancreatic cancer.
Analysis of single-cell data in pancreatic adenocarcinoma.
Exploration of NRP protein mechanisms and therapeutic potential.

Main Results

NRP proteins are intricately involved in pancreatic cancer at the cellular level.
Single-cell analysis reveals specific roles of NRP proteins in pancreatic adenocarcinoma.
NRP proteins demonstrate potential as therapeutic targets across various treatment modalities.

Conclusions

Understanding NRP protein functions is crucial for developing novel pancreatic cancer therapies.
NRP-1 and NRP-2 represent promising targets for overcoming therapy resistance.
Further research into NRP pathways may offer new directions for pancreatic cancer treatment.

Keywords:

fibroblast growth factor neuropilin pancreatic cancer semaphorin tumor microenvironment